{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:30:11Z","timestamp":1771036211137,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI159143-01A1"],"award-info":[{"award-number":["K23AI159143-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R13AR082704"],"award-info":[{"award-number":["R13AR082704"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI154659"],"award-info":[{"award-number":["U01AI154659"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01HG010863"],"award-info":[{"award-number":["R01HG010863"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI152183"],"award-info":[{"award-number":["R01AI152183"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaip.2024.04.053","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:20:00Z","timestamp":1714987200000},"page":"2591-2598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patient-Reported Outcome Measures in Food and Drug Allergy"],"prefix":"10.1016","volume":"12","author":[{"given":"Aikaterini","family":"Anagnostou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Dantzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey Dunn","family":"Galvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.04.053_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11882-017-0708-z","article-title":"Patient-centered outcomes in food allergy","volume":"17","author":"Polk","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.04.053_bib2","first-page":"61","article-title":"Article commentary: patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Heal Serv Insights"},{"key":"10.1016\/j.jaip.2024.04.053_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.f167","article-title":"Patient reported outcome measures could help transform healthcare","volume":"346","author":"Black","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2024.04.053_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2222.2008.02978.x","article-title":"Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity","volume":"38","author":"DunnGalvin","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaci.2008.05.008","article-title":"Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents","volume":"122","author":"Blok","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2222.2010.03454.x","article-title":"Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - Parent Form in children 0-12 years following positive and negative food challenges","volume":"40","author":"DunnGalvin","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s11136-012-0295-3","article-title":"Validation of the Food Allergy Quality of Life-Parental Burden Questionnaire in the UK","volume":"22","author":"Knibb","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaip.2024.04.053_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.2022.11238","article-title":"Patient-reported outcome measures in clinical research","volume":"328","author":"Weinfurt","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.04.053_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2023.01.033","article-title":"Endpoints and outcomes after immunotherapy for food allergy: what is meaningful for patients?","volume":"11","author":"Lloyd","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5 suppl 1","key":"10.1016\/j.jaip.2024.04.053_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years","volume":"45","author":"Cella","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.jaip.2024.04.053_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/erp.11.74","article-title":"Advancing PROMIS\u2019s methodology: results of the Third Patient-Reported Outcomes Measurement Information System (PROMIS) Psychometric Summit. Vol. 11","volume":"11","author":"Carle","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jaip.2024.04.053_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2024.04.053_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.04.053_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.04.053_bib15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.04.053_bib16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.04.053_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40521-020-00274-8","article-title":"Patients\u2019 perspectives and needs on novel food allergy treatments in the United States","volume":"8","author":"Herbert","year":"2021","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.anai.2020.06.023","article-title":"Outcomes for clinical trials of food allergy treatments","volume":"125","author":"Sim","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib19","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1016\/j.jaip.2021.07.047","article-title":"Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial","volume":"9","author":"Dunn","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib20","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.jaip.2021.05.020","article-title":"Improvement in health-related quality of life in food-allergic patients: a meta-analysis","volume":"9","author":"Cao","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaip.2020.08.015","article-title":"Improvements in quality of life in children following epicutaneous immunotherapy (EPIT) for peanut allergy in the PEPITES and PEOPLE studies","volume":"9","author":"DunnGalvin","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaip.2022.11.036","article-title":"Omalizumab in IgE-mediated food allergy: a systematic review and meta-analysis","volume":"11","author":"Zuberbier","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib23","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.jaip.2019.03.011","article-title":"Food allergy research priorities: results from a patient-centered study","volume":"7","author":"Bilaver","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/pai.13464","article-title":"Food allergy treatment value: child caregiver and patient perspectives","volume":"32","author":"Abdelwadoud","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib25","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/cea.14225","article-title":"Information needs of patients considering oral immunotherapy for food allergy","volume":"52","author":"Mack","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jaip.2018.05.035","article-title":"Goals and motivations of families pursuing oral immunotherapy for food allergy","volume":"7","author":"Dunlop","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib27","article-title":"Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy","volume":"7","author":"Blackman","year":"2019","journal-title":"Ther Adv Vaccines Immunother"},{"key":"10.1016\/j.jaip.2024.04.053_bib28","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.jaip.2021.04.058","article-title":"Heterogeneity in parent preferences for peanut desensitization therapy","volume":"9","author":"Hung","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-018-8700-5","article-title":"Psychosocial mediators of change and patient selection factors in oral immunotherapy trials","volume":"55","author":"Dunn Galvin","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40521-022-00306-5","article-title":"The economic burden of food allergy: what we Know and what we need to learn","volume":"9","author":"Fong","year":"2022","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anai.2023.12.030","article-title":"Skin as the target for allergy prevention and treatment","volume":"133","author":"Marques-Mejias","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltac006","article-title":"New and emerging concepts and therapies for the treatment of food allergy","volume":"2","author":"Hwang","year":"2022","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jaip.2024.04.053_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ACI.0000000000000719","article-title":"Prevention of food allergy: can we stop the rise of IgE mediated food allergies?","volume":"21","author":"Santos","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","article-title":"The economic impact of childhood food allergy in the United States","volume":"167","author":"Gupta","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2024.04.053_bib35","first-page":"418","article-title":"The impact of double-blind placebo- controlled food challenge (DBPCFC) on the socioeconomic cost of food allergy in Europe","volume":"24","author":"Cerecedo","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/eurpub\/ckt010","article-title":"Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness study","volume":"23","author":"Fox","year":"2013","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jaip.2024.04.053_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13223-021-00515-8","article-title":"Mothers of children with food allergies report poorer perceived life status which may be explained by limited career choices","volume":"17","author":"Frykas","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13223-021-00530-9","article-title":"The excess costs of childhood food allergy on Canadian families: a cross-sectional study","volume":"17","author":"Golding","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib39","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12443","article-title":"Socioeconomic evaluation of well-characterized allergy to staple foods in adults","volume":"69","author":"Jansson","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaip.2014.09.021","article-title":"Household costs associated with objectively diagnosed allergy to staple foods in children and adolescents","volume":"3","author":"Protudjer","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100061","article-title":"Pediatric food allergy-related household costs are influenced by age, but not disease severity","volume":"12","author":"Wai","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"5 part 1","key":"10.1016\/j.jaip.2024.04.053_bib42","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1475-6773.2009.00993.x","article-title":"Social and economic costs of food allergies in Europe: development of a questionnaire to measure costs and health utility","volume":"44","author":"Fox","year":"2009","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jaip.2024.04.053_bib43","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jval.2021.02.010","article-title":"Cost-effectiveness of food allergy interventions in children: a systematic review of economic evaluations","volume":"24","author":"Fanning","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.jaip.2024.04.053_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3242","article-title":"Estimation of health and economic benefits of commercial peanut immunotherapy products: a cost-effectiveness analysis","volume":"2","author":"Shaker","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2024.04.053_bib45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.puhe.2012.06.003","article-title":"Costs of allergic diseases from birth to two years in Finland","volume":"126","author":"Alanne","year":"2012","journal-title":"Public Health"},{"key":"10.1016\/j.jaip.2024.04.053_bib46","first-page":"1","article-title":"Nutrition economic evaluation of allergy treatment in infants and children: background for probiotic studies","volume":"23","author":"Alanne","year":"2012","journal-title":"Microb Ecol Health Dis"},{"key":"10.1016\/j.jaip.2024.04.053_bib47","first-page":"357","article-title":"Prevalence and costs of five chronic conditions in children","volume":"32","author":"Miller","year":"2016","journal-title":"J\u00a0Sch Nurs"},{"key":"10.1016\/j.jaip.2024.04.053_bib48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.anai.2010.12.014","article-title":"Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire","volume":"106","author":"Baiardini","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11136-015-1051-2","article-title":"Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity","volume":"25","author":"Bavbek","year":"2016","journal-title":"Qual life Res"},{"key":"10.1016\/j.jaip.2024.04.053_bib50","first-page":"129","article-title":"Assessment of validity and reliability of Drug Hypersensitivity Quality of Life Questionnaire: the Dutch experience","volume":"49","author":"Moayeri","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/intqhc\/mzy207","article-title":"Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study","volume":"31","author":"Chongpison","year":"2019","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jaip.2024.04.053_bib52","first-page":"508","article-title":"Cross-cultural adaptation and linguistic validation of the Spanish version of the drug hypersensitivity quality of life questionnaire","volume":"23","author":"Gastaminza","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12955-021-01749-1","article-title":"Drug Hypersensitivity Quality of Life Questionnaire: validation procedures and first results of the Portuguese version","volume":"19","author":"Dias de Castro","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jaip.2024.04.053_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5415\/apallergy.0000000000000020","article-title":"Validation of the Chinese drug hypersensitivity quality of life questionnaire: role of delabeling","volume":"13","author":"Mak","year":"2023","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2024.04.053_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.23822\/EurAnnACI.1764-1489.115","article-title":"Development and validation of the parent-reported Drug Hypersensitivity Quality of Life Questionnaire","volume":"52","author":"Yuenyongviwat","year":"2020","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.053_bib56","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaip.2024.02.016","article-title":"Enhancing patient-reported outcome measures for drug hypersensitivity: a\u00a0validated 6-item Quality-of-Life Questionnaire for Patients with Drug Hypersensitivity","volume":"12","author":"Mak","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib57","first-page":"480","article-title":"Clarification of drug allergy information using a standardized drug allergy questionnaire and interview","volume":"43","author":"Harig","year":"2018","journal-title":"P\u00a0T"},{"key":"10.1016\/j.jaip.2024.04.053_bib58","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.jaip.2019.05.017","article-title":"Quality of life in patients with allergic reactions to medications: influence of a drug allergy evaluation","volume":"7","author":"Gastaminza","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib59","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jaip.2023.03.012","article-title":"Health-related quality of life and mental health in drug hypersensitivity reactions and drug-induced anaphylaxis: a systematic review and meta-analysis","volume":"11","author":"Martini","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamadermatol.2022.0484","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis-coordinating research priorities to move the field forward","volume":"158","author":"Phillips","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2024.04.053_bib62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1213889","article-title":"Updates in SJS\/TEN: collaboration, innovation, and community","volume":"10","author":"Marks","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.jaip.2024.04.053_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2022.992696","article-title":"Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care","volume":"4","author":"Shanbhag","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.jaip.2024.04.053_bib65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/PPA.S285256","article-title":"Quality of life of drug reaction with eosinophilia and systemic symptom (DRESS) and Stevens-Johnson syndrome (SJS) and\/or toxic epidermal necrolysis (TEN) patients","volume":"15","author":"Perwitasari","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaip.2024.04.053_bib66","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaip.2023.10.022","article-title":"Drug reaction with eosinophilia and systemic symptoms: medication adherence and quality of life in survivors","volume":"12","author":"Jaggers","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.053_bib67","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamadermatol.2021.1136","article-title":"Long-term physical and psychological outcomes of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"157","author":"Hoffman","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2024.04.053_bib68","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bjd.14799","article-title":"Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"175","author":"Dodiuk-Gad","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2024.04.053_bib69","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdin.2023.01.012","article-title":"Physical and mental health impact of Stevens-Johnson syndrome\/toxic epidermal necrolysis and post-hospital discharge care: identifying practice gaps","volume":"11","author":"Coromilas","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaip.2024.04.053_bib70","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/j.jaip.2020.08.018","article-title":"Patient characteristics and concerns about drug allergy: a report from the United States Drug Allergy Registry","volume":"8","author":"Blumenthal","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824004616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824004616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T09:45:28Z","timestamp":1728294328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824004616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213219824004616"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.04.053","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcome Measures in Food and Drug Allergy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}